Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,230.00    -160.00 (-2.97%)
Bid:
5,195.00
Ask:
5,205.00
Spread: 10.00 (0.192%)
Market Cap: £3.80b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Trading Statement

13 Oct 2016 10:54

RNS Number : 4689M
Renishaw PLC
13 October 2016
Β 

Renishaw plc

Trading update

13th October 2016

Β 

Ahead of the AGM being held at noon today, we are providing a short trading update as follows:

Β 

Renishaw plc, the global high-precision metrology and healthcare manufacturer, publishes this trading update for the three months ended 30th September 2016. It contains unaudited information that covers the first quarter and the period since.

Β 

Trading activity

Revenue for the first quarter of the current financial year was Β£112.8m, compared with Β£98.2m for the corresponding period last year, with growth of 15%. There was growth in all regions, especially the Far East at 22% (9% at constant exchange rates) and Europe at 13% (3% at constant exchange rates).

Β 

By business sector, revenue in our metrology business increased by 16% to Β£108.8m compared with Β£93.7m last year, with underlying growth at constant exchange rates of 7%. Revenue in our healthcare business was Β£4.0m compared with Β£4.5m last year.

Β 

Profit before tax for the first quarter amounted to Β£14.1m (including a currency benefit of Β£3.7m) compared with Β£16.3m last year.

Β 

The Group's cost base reflects investments made in the previous year, including an increase in labour costs supporting global marketing expansion, further strategic investment in our research and development programmes and investment in skills for future growth. Across the Group, we continue to focus on our operating costs. Exchange rate movements have given rise to higher overseas operating costs in Sterling terms.

Β 

Renishaw Diagnostics Limited ("RDL")

Following an extensive review of the business, the Board has decided to discontinue operations at RDL, resulting in the 33 staff directly employed by RDL now being on notice of redundancy. Significant efforts have been made to find a collaboration or acquisition partner, however there have been no acceptable offers to date that could take RDL forward as a going concern. We continue to look at opportunities for the sale of RDL assets and to support employees in finding alternative employment. We would like to express our thanks to the employees of RDL for their considerable efforts since the company was formed in 2007.

The full carrying value of assets on the consolidated balance sheet which are at risk of impairment loss, along with estimated cessation costs, is expected to be in the region of Β£4.9m. The resultant costs, net of proceeds from asset disposals, will be reflected in the half year results. The operating costs of RDL in the 2016 financial year were Β£3.2m.

Financial positionΒ 

The Group balance sheet remains strong with net cash balances of Β£27.8m as at 30th September 2016 (30th June 2016: Β£21.3m), excluding the escrow account of Β£15.3m (30th June 2016: Β£15.3m) which provides additional security for the UK defined benefit pension scheme.

Β 

Outlook

The Board remains confident in the future prospects of the Group and, as stated in my statement in July 2016, we continue to anticipate growth in both revenue and profit in this financial year.

Β 

Sir David McMurtry

CBE, RDI, FRS, FREng, CEng, FIMechE

Chairman and Chief Executive

Β 

13th October 2016

Β 

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

Telephone number 01453 524524

Website www.renishaw.com Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTEANEDFSDKFEF
Date   Source Headline
15th May 20097:00 amRNSInterim Management Statement
14th May 20092:11 pmRNSDirectorate Change
30th Mar 20092:08 pmRNSHolding(s) in Company
11th Mar 20098:00 amRNSTrading Statement
9th Feb 20092:29 pmRNSPatent litigation settlement
28th Jan 20097:30 amRNSHalf Yearly Report
23rd Jan 20093:32 pmRNSTrading statement & Interim results preview
24th Nov 20085:48 pmRNSAcquisition
30th Oct 20089:50 amRNSDirector/PDMR Shareholding
14th Oct 20084:43 pmRNSSecond Price Monitoring Extn
14th Oct 20084:38 pmRNSPrice Monitoring Extension
10th Oct 20081:11 pmRNSResult of AGM
10th Oct 20087:30 amRNSInterim Management Statement
4th Sep 200810:18 amRNSAnnual Information Update
18th Aug 20088:47 amRNSAnnual Report and Accounts
23rd Jul 20087:30 amRNSFinal Results
20th Jun 20088:10 amRNSDirectorate Change
19th Jun 20088:38 amRNSPatent legal proceeedings
8th May 20084:20 pmRNSStatement -Voting arrangement
8th May 20087:30 amRNSInterim Management Statement
6th May 20088:59 amRNSHolding(s) in Company
3rd Apr 20083:06 pmRNSHolding(s) in Company
3rd Apr 20082:28 pmRNSHolding(s) in Company
3rd Apr 20082:19 pmRNSDirector/PDMR Shareholding
25th Mar 20082:20 pmRNSHolding(s) in Company
21st Feb 20088:18 amRNSHolding(s) in Company
28th Jan 20082:10 pmRNSHolding(s) in Company
23rd Jan 20087:30 amRNSInterim Results
12th Oct 20072:41 pmRNSResult of AGM
12th Oct 200710:44 amRNSHolding(s) in Company
12th Oct 200710:43 amRNSHolding(s) in Company
12th Oct 20077:00 amRNSInterim Management Statement
20th Sep 20071:46 pmRNSNotice of EGM
7th Sep 200710:05 amRNSAnnual Information Update
17th Aug 20073:50 pmRNSAnnual Report and Accounts
25th Jul 20073:22 pmRNSHolding(s) in Company
25th Jul 20077:30 amRNSFinal Results
9th Jul 20074:30 pmRNSAcquisition
9th Jul 20071:53 pmRNSHolding(s) in Company
13th Jun 200711:26 amRNSHolding(s) in Company
11th Jun 20072:32 pmRNSTrading Statement
4th Jun 200711:42 amRNSRelated Party Transaction
24th Apr 200711:16 amRNSHolding(s) in Company
23rd Apr 200711:46 amRNSIssue of Equity
30th Mar 20078:17 amRNSAcquisition
27th Mar 20072:10 pmRNSHolding(s) in Company
20th Mar 20071:39 pmRNSHolding(s) in Company
9th Mar 20078:49 amRNSHolding(s) in Company
9th Mar 20078:46 amRNSHolding(s) in Company
26th Jan 20072:34 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.